// App-Quantinova.ai

2323 : Tarextumab (Anti-NOTCH2/3) reverses NOTCH2 and NOTCH3-dependent tumorigenicity and metastases in small cell lung cancer

Researchers

Presenter

  • Jalpa Shah

Principal Investigators

  • Gilbert -Young

  • Jie Wei

  • Marcus Fischer

  • Wan-Ching Yen

  • Belinda Cancilla

  • Ann Kapoun

  • John Lewicki

  • Jennifer Cain

  • Timothy Hoey

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • OncoMed Pharmaceutic

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Small cell lung cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • cisplatin + irinotecan

  • Tarextumab

  • Etoposide

  • Etoposide phosphate

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved